Related Experiment Video
Updated: May 11, 2026

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Harnessing exosomes for advanced drug delivery in cancer theranostics
Meenakshi Dhanawat1, Garima2, Kashish Wilson3
1Amity Institute of Pharmacy, Amity University Haryana, Gurugram, Haryana 122413, India.
Abstract:
Exosomes are nanoscale extracellular vesicles released by various cell types and have gained significant attention for their ability to transport diverse bioactive molecules. Their inherent stability, tumor-targeting capability, biocompatibility, and low immunogenicity make them promising candidates for drug delivery in cancer therapy. Despite these advantages, a gap remains between their biological understanding and optimal clinical application. Exosomes play a dual role in cancer as both therapeutic delivery systems and mediators of disease progression. Their phospholipid membrane enhances targeted drug delivery, while exosome-associated biomarkers offer new opportunities for cancer diagnosis. This review provides a comprehensive overview of exosome biogenesis, isolation methods, cargo loading strategies, roles in cancer progression, and applications in drug delivery and theranostics. It also highlights the advantages, limitations, and current clinical advancements of exosome-based systems. Overall, exosomes represent a cutting-edge platform with the potential to transform future cancer diagnosis and treatment.
More Related Videos
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Tumor Immunotherapy

